ARA-290
Erythropoietin-derived peptide selectively activating the innate repair receptor to reduce neuropathic response.
Open ARA-290 in the 3D analyzerAnalytical specification
| Empirical formula | C51H84N16O21 |
|---|---|
| Molecular weight | 1257.3 g/mol |
| Isoelectric point (pI) | 4.15 |
| Assay purity (HPLC) | 99.45% |
| Retention time | 5.85 min |
| Peak area / height | 10800 / 890 |
| Reference batch | AR-2026-N77 |
| Research category | Tissue Healing & Joint Recovery |
| Amino-acid sequence | pGlu-E-Q-L-E-R-A-L-N-S-S |
Research characteristics
IRR Activation
Selectively binds tissue protection complex
Neuropathic Relief
Suppresses chronic mechanical hypersensitivity
Ischemic Healing
Aids microvascular cell recovery
Anti-cytokine
Suppresses macrophage inflammatory bursts
Reconstitution
Use the interactive reconstitution calculator to convert vial size (mg), bacteriostatic water volume (ml) and target dose (mcg) into a syringe draw on a standard 100-unit insulin syringe. Open the dosage calculator.
Related tissue healing & joint recovery compounds
BPC-157
Pentadecapeptide demonstrating remarkable tissue-protective and gastro-intestinal healing profiles.
TB-500 (Thymosin B4)
Synthetic Thymosin Beta-4 active fragment involved in actin sequestration and cell migration processes.
Thymosin Beta-4
Bio-identical full chain Thymosin Beta-4 governing cellular migration and vascular recovery.
Pentadecapeptide (PL-10)
Purified alternative sequence variant of BPC-157 specializing in joint and soft-tissue models.
KPV (Lys-Pro-Val)
Tripeptide model exhibiting powerful anti-inflammatory effects through melanocortin receptors.
GHK-Cu
Naturally occurring copper complex stimulating extracellular matrix proteins and stem cell remodeling.